Lurasidone augmentation to clozapine in treatment resistant schizophrenia: A pilot study

INTRODUCTION: Treatment resistant schizophrenia still represents a major clinical and pharmacological challenge.30% of patients diagnosed with schizophrenia is characterised by a poor response to at least two different antipsychotics administered for a proper period of time and at adequate doses. Cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Arienti, V., Civardi, S. C., Besana, F., Mazzoni, F., Carnevale Miacca, G., Brondino, N., Politi, P., Olivola, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434131/
http://dx.doi.org/10.1192/j.eurpsy.2023.684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434131/
http://dx.doi.org/10.1192/j.eurpsy.2023.684

Ejemplares similares